Relief, NeuroRx say RLF-100 emergency treatment helps COVID-19 patients
In June the US Food and Drug Administration granted fast-track designation to RLF-100 for treatment of respiratory distress in COVID-19.
Lung cells infected with coronavirus(photo credit: YAAKOV NAHMIAS)